Anti tumor compounds isolated from higher plaints

Studies in Natural Products Chemistry

Volumn 24, Issue PART E, 2000, Pages 269-350

  Itokawa, Hideji ^a   Takeya, Koichi ^a   Hitotsuyanagi, Yukio ^a   Morita, Hiroshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44849102850     PISSN: 15725995     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1572-5995(00)80048-4     Document Type: Chapter

References (155)

1. A Review. Itokawa H. Research on Antineoplastic Drugs from Natural Sources Especially from Higher Plants. Yakugaku Zasshi 108 9 (1988) 824-841
2. Sawada S., Okajima S., Aiyama R., Nokata K., Furuta T., Yokokura T., Sugino E., Yamaguchi K., and Miyasaka T. Chem. Pharm. Bull. 39 6 (1991) 1446-1454
3. Grever M., Suffness M., and Cragg G. the Symposium on "Cancer and Aids" at the Annual Meeting of the Pharmaceutical Congress of Japan. Tokyo (1991)
4. Boyd R.W., Shoemaker R.H., Cragg G.M., and Suffness M. New Avenues of Investigation of Marine Biologicals in the Anticancer Drug Discovery Program of the National Cancer Institute. In: Jefford C.W., Rinehart K.L., and Shield L.S. (Eds). Pharmaceuticals and the Sea (1988), Technomic Publishing Co., Tokyo 27-43
5. Suffness M. New Approaches to the Discovery of Antitumor Agents. In: Hostettmann K., and Lea P.J. (Eds). Biologically Active Natural Products (1987), Clarendon Press, Lancaster, Penssylvania 85-104
6. No. 36. Suffness M. Development of Antitumor Natural Products at the National Cancer Institute. In: Takeuchi T., Nitta K., and Tanaka N. (Eds). Gann Monograph on Cancer Research (1989), Japan Scientific Societies Press, Oxford 21-44
7. Goldin A., Schepartz S.A., Venditti J.M., and Devita Jr. V.T. Historical Development and Current Strategy of the National Cancer Institute Drug Development Program. In: Devita Jr. V.T., and Buseh H. (Eds). Methods in Cancer Research (1979), Academic Press, Tokyo 165-245
8. Venditti J.M., Wesley R.A., and Plowman J. Current NCI Preclinical Antitumor Screening In Vivo. Results of Tumor Panel Screening 1976 - 1982 and Future Directions. Adv. Pharmacol. Chemother. 20 (1984) 1-20
9. Driscoll J.S. The Preclinical New Drug Research Program of the National Cancer Institute. Cancer Treat. Rep. 68 (1984) 63-76
10. Cassady J.M., Baird W.M., and Chang C.-J. Natural Products as A Source of Potential Cancer Chemotherapeutic and Chemopreventive Agents. J. Nat. Prod. 53 (1990) 23-41
11. In: Cassady J.M., and Douros J.D. (Eds). Anticancer Agents Based on Natural Product Models (1980), Academic Press, New York
12. Suffness M., and Douros J. Current Status of the NCI Plant and Animal Product Program. J. Nat. Prod. 45 (1982) 1-14
13. In: Aszalos A. (Ed). Antitumor Compounds of Natural Origin (1981), CRC Press, New York
14. In: Pettit G.R., Cragg G.M., and Herald C.L. (Eds). Biosynthetic Products for Cancer Chemotherapy (1985), Elsevier, Boca Raton, Florida
15. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., and Boyd M.R. Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay. Cancer Res. 48 (1988) 589-601
16. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., and Boyd M.R. Evaluation of a Soluble Tetrazolium/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines. Cancer Res. 48 (1988) 4827-4833
17. Oldham R.K. Biological Response Modifiers Program. J. Biol. Resp. Modif. 1 (1982) 81-100
18. In: Talmadge J.E., Fidler I.J., and Oldham R.K. (Eds). Screening for Biological Response Modifiers (1985), Kluwer Academic Publishers, New York
19. Suffness M. The Discovery and Development of Antitumor Drugs from Natural Products. In: Vlietinck A.J., and Dommisse R.A. (Eds). Advances in Medicinal Plant Research (1985), Wissenschat liche Verlagsgeselschaft mbH, Boston 101-133
20. Part A. Suffness M., and Douros J. Drugs of Plant Origin. In: Devita V.T., and Bush H. (Eds). Methods in Cancer Research (1979), Academic Press, Stuttgart 73-126
21. No. 36. Tsukagoshi S. Antitumor Natural Products Other Than Antibiotics under Development in Japan. In: Takeuchi T., Nitta K., and Tanaka N. (Eds). Gann Monograph on Cancer Research (1989), Japan Scientific Societies Press, New York 45-55
22. Pettit G.R., Smith C.R., and Singh S.B. Recent Advances in the Chemistry of Plant Antineoplastic Constituents. In: Hostettmann K., and Lea P.J. (Eds). Biologically Active Natural Products (1987), Clarendon Press, Tokyo 105-116
23. No. 36. Takeuchi T., and Nitta K. Novel Antitumor Antibiotics Developed in Japan. In: Takeuchi T., Nitta K., and Tanaka N. (Eds). Gann Monograph on Cancer Research (1989), Japan Scientific Societies Press, Oxford 3-19
24. Douros J.D. National Cancer Institute's Fermentation Development Program. Recent Results Cancer Res. 63 (1978) 33-48
25. Itokawa H., Watanabe K., and Mihashi S. Screening Test for Antitumor Activity of Crude Drugs (I). Shoyakugaku Zasshi 33 (1979) 95-102
26. Itokawa H., Watanabe K., Mihara K., and Takeya K. Screening Test for Antitumor Activity of Crude Drugs (II). Shoyakugaku Zasshi 36 (1982) 145-149
27. Itokawa H., Hirayama F., Tsuruoka S., Mizuno K., Takeya K., and Nitta A. Screening Test for Antitumor Activity of Crude Drugs (III), Studies on Antitumor Activity of Indonesian Medicinal Plants. Shoyakugaku Zasshi 44 (1990) 58-62
28. A review. Kingston D.G.I., Molinero A.A., and Rimoldi J.M. Progress in the Chemistry of Organic Natural Products 61 (1993) 1-206
29. In: Suffness M. (Ed). In Taxol, "Science and Applications" (1995), CRC Press, Tokyo
30. Shigemori H., Wang X.-X., Yoshida N., Kobayashi J., and X-Z T. New Taxoids from Japanese Yew Taxus cuspidata. Chem. Pharm. Bull. 45 7 (1997) 1205-1208
31. Tanaka K., Fuji K., Yokoi T., and Shingu T. Structures of Taxchinins L and M, Two New Diterpenoidsfrom Taxus chinensis var. mairei. Chem. Pharm. Bull. 44 9 (1996) 1770-1774
32. Morita H., Gonda A., Wei L., Yamamura Y., Takeya K., and Itokawa H. Taxuspinananes A and B, New Taxoids from Taxus cuspidata var. nana. J. Nat Prod. 60 4 (1997) 390-392
33. Morita H., Wei L., Gonda A., Takeya K., Itokawa H., Fukaya H., Shigemori H., and Kobayashi J. Crystal and Solution State Conformations of Two Taxoids, Taxinine and Taxinine B. Tetrahedron 53 13 (1997) 4621-4626
34. Morita H., Wei L., Gonda A., Takeya K., and Itokawa H. A Taxoid from Taxus cuspidata var. nana. Phytochemistry 46 3 (1997) 583-586
35. Morita H., Gonda A., Wei L., Takeya K., and Itokawa H. 3D QSAR Analysis of Taxoids from Taxus cuspidata vsr. nana by Comparative Molecular Field Approach. Bioorg. & Med Chem. Lett. 7 18 (1997) 2387-2392
36. Itokawa H., Totsuka N., Takeya K., Watanabe K., and Obata E. Antitumor Principles from Casearia sylvestris Sw. (Flacourtiaceae), Structure Elucidation of New Clerodane Diterpenes by 2-D NMR Spectroscopy. Chem. Pharm. Bull. 36 (1988) 1585-1588
37. Itokawa H., Totsuka N., Morita H., Takeya K., Iitaka Y., Schenkel E.P., and Motidome M. New Antitumor Principles, Casearins A-F, from Casearia sylvestris Sw. (Flacourtiaceae). Chem. Pharm. Bull. 38 (1990) 3384-3388
38. Morita H., Nakayama M., Kojima H., Takeya K., Itokawa H., Schenkel E.P., and Motidome M. Structures and Cytotoxic Activity Relationship of Casearins New Clerodane Diterpenes from Gasearia sylvestris Sw. Chem. Pharm. Bull. 39 (1991) 693-697
39. Morita H., Kishi E., Takeya K., Itokawa H., and Tanaka O. New Quassinoids from the Roots of Eurycoma longifolid. Chem. Lett. (1990) 749-752
40. Itokawa H., Kishi E., Morita H., Takeya K., and Iitaka Y. Eurylene, A New Squalene-Type Triterpene from Eurycoma longifolia. Tetrahedron Lett. 32 (1991) 1803-1804
41. Itokawa H., Morita H., Katou I., Takeya K., Cavalheiro A.J., de Oliveira R.C.B., Ishige M., and Motidome M. Cytotoxic Diterpenes from the Rhizomes of Hedychium coronarium. Planta Medica 54 (1988) 311-315
42. Ittokawa H., Morita H., Takeya K., and Motidome M. Diterpenes from Rhizomes of Hedychium coronarium. Chem. Pharm. Bull. 36 (1988) 2682-2684
43. Itokawa H., Shirota O., Ikuta H., Morita H., Takeya K., and Iitaka Y. Triterpenes from Maytenus ilicifolia. Phytochemistry 30 (1991) 3713-3716
44. Itokawa H., Shirota O., Morita H., Takeya K., Tomioka N., and Itai A. New Triterpene Dimers from Maytenus ilicifolia. Tetrahedron Lett. 31 (1990) 6881-6882
45. Shirota O., Morita H., Takeya K., and Itokawa H. Revised structures of cangorosins, triterpene dimers from Maytenus ilicifolia. J. Nat. Prod. 60 2 (1997) 111-115 These structures were revised in the literature
46. Shirota O., Morita H., Takeya K., and Itokawa H. Structures of Xuxuarines, Stereoisomeric Triterpene Dimers from Maytenus chuchuhuasca. 4. Tetrahedron 51 (1995) 1107-1120 The related literatures were as follows, a)
47. Shirota O., Morita H., Takeya K., and Itokawa H. Novel Stereoisomeric Triterpene Dimers, Xuxuarines Aα and Aβ, from Maytenus chuchuhuasca. Chemistry Letters (1995) 101-102
48. Shirota O., Morita H., Takeya K., and Itokawa H. Five New Triterpene Dimers from Maytenus chuchuhuasca. J. Nat. Prod. 60 11 (1997) 1100-1104
49. Shirota O., Morita H., Takeya K., and Itokawa H. New Geometric and Stereoisomeric Triterpene Dimers from Maytenus chuchuhuasca. Chem. Pharm. Bull. 46 1 (1998) 102-106
50. Itokawa H., Hirayama F., Funakoshi K., and Takeya K. Studies on the Antitumor Bisabolane Sesquiterpenoids Isolated from Curcuma xanthorrhiza. Chem. Pharm. Bull 33 (1985) 3488-3492
51. Uehara S., Yasuda I., Takeya K., and Itokawa H. New Bisabolane Sesquiterpenoids from the Rhizomes of Curcuma xanthorrhiza (Zingiberaceae). Chem. Pharm. Bull. 37 (1989) 237-240
52. Uehara S., Yasuda I., Takeya K., Itokawa H., and Iitaka Y. New Bisabolane Sesquiterpenoids from the Rhizomes of Curcuma xanthorrhiza (Zingiberaceae) II. Chem. Pharm. Bull. 38 (1990) 261-263
53. Itokawa H., Ichihara Y., Watanabe K., and Takeya K. An Antitumor Principle from Euphorbia lathyris. Planta Medica 55 (1989) 271-272
54. Itokawa H., Xu J.-P., and Takeya K. Studies on Chemical Constituents of Antitumor Fraction from Periploca sepium Bge. I. Chem. Pharm. Bull. 55 (1987) 4524-4529
55. Itokawa H., Xu J.-P., Takeya K., Watanabe K., and Shoji J. Studies on Chemical Constituents of Antitumor Fraction from Periploca sepium. II. Structures of New Pregnane Glycosides Periplocosides A B and C. Chem. Pharm. Bull. 36 (1988) 982-987
56. Itokawa H., Xu J.-P., and Takeya K. Studies on Chemical Constituents of Antitumor Fraction from Periploca sepium IV. Structures of New Pregnane Glycosides, Periplocosides D, E, L and M. Chem. Pharm. Bull. 36 (1988) 2084-2089
57. Itokawa H., Xu J.-P., and Takeya K. Studies on Chemical Constituents of Antitumor Fraction from Periploca sepium V. Structures of New Pregnane Glycosides, Periplocosides J, K, F and O. Chem. Pharm. Bull. 36 (1988) 4441-4446
58. Itokawa H., Xu J.-P., and Takeya K. Pregnane Glycosides from An Antitumor Fraction of Periploca sepium. Phytochemistry 27 (1988) 1173-1179
59. Xu J.-P., Takeya K., and Itokawa H. Pregnanes and Cardenolides from Periploca sepium. Phytochemistry 29 (1990) 344-346
60. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. Drupangtonine, a Novel Antileukemic Alkaloid from Cepalotaxus harringtonia var. Drupacea. Bioorg. & Med Chem. Lett. 6 14 (1996) 1689-1690
61. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. Alkaloids from Cephalotaxus harringyonia. Photochemistry 43 1 (1996) 299-303
62. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. New Cephalotaxus Alkaloids from Cephalotaxus harringtonia var. drupacea. J. Nat. Prod. 59 (1996) 965-967
63. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. Cephalotaxidine, a Novel Dimeric Alkaloid from Cepharotaxus harringtonia var. drupacea. Tetrahedron Lett. 37 39 (1996) 7053-7054
64. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. New Oxygenated Cephalotaxus alkaloids from Cephalotaxus harringtonia var. drupacea. J. Nat. Prod. 59 (1996) 1192-1195
65. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. Ester-Type Cephalotaxus Alkaloids from Cephalotaxus harringtonia var. drupacea. Phytochemistry 44 4 (1997) 735-738
66. Takano, Yasuda I., Nishijima M., Hitotsuyanagi Y., Takeya K., and Itokawa H. Modification of the skeleton of Homoharringtonine through unusual Rearrangements. J. Org. Chem. 62 (1997) 8251-8254
67. Itokawa H., Tsuruoka S., Takeya K., Mori N., Sonobe T., Kosemura S., and Hamanaka T. An Antitumor Morphinane Alkaloid Sinococuline, from Cocculus trilobus. Chem. Pharm. Bull. 35 (1987) 1660-1662
68. H. Itokawa, K. Takeya, N. Mori, T. Sonobe, M. Ogoshi, K. Yamakawa and T. Hamanaka, "Isolation and Antitumor Activity of FK-2000 and FK-3000, Two New Alkaloids from Sinomenium acutum", Jpn. Kokai Tokkyo Koho JP 62,289,565 [87,289,565].
69. H. Itokawa, K. Takeya, S. Tsuruoka, N. Mori, T. Sonobe, S. Kosemura, N. Okamura, T. Ogawa, M. Ogoshi, K. Yamakawa and T. Hamanaka, "Isolation of Antitumor Alkaloid FK1000", Jpn Kokai Tokkyo Koho JP 62,263,158 [87, 263, 158].
70. Itokawa H., Inamatsu M., and Takeya K. A Cytotoxic Principle from Evodia rutaecarpa. Shoyakugaku Zasshi 44 (1990) 135-137
71. Itokawa H., Totsuka N., Nakahara K., Takeya K., Lepoittevin J.-P., and Asakawa Y. Antitumor Priciples from Ginkgo biloba L. Chem. Pharm. Bull. 35 (1987) 3016-3020
72. Itokawa H., Totsuka N., Nakahara K., Maezuru M., Takeya K., Kondo M., Inamatsu M., and Morita H. A Quantitative Structure-Activity Relationship for Antitumor Activity of Long-Chain Phenols from Ginkgo biloba L. Chem. Pharm. Bull. 37 (1989) 1619-1621
73. Esaki T. Quantitative Drug Design Studies. VI Quantitative Structure-Activity Relationships of Ionizable Substances: Antibacterial Activities of Phenols. Chem. Pharm. Bull. 35 (1987) 3105-3111
74. Itokawa H., Morita H., Sumitomo T., Totsuka N., and Takeya K. Antitumor Priciples from Alpinia galanga. Planta Medica 53 (1987) 32-33
75. In: Burkill I.H. (Ed). A Dictionary of the Economic Products of the Malay Peninsula (1966), Ministry of Agriculture and Co-operatives, Boca Raton, Fl 1323
76. de Pooter H.L., Omar M.N., Coolsaet B.A., and Schamp N.M. The Essential Oil of Greater Galanga (Alpinia galanga) from Malaysia. Phytochemistry 24 (1985) 93-96
77. Mitsui S., Kobayashi S., Nagohori H., and Ogiso A. Constituents from Seeds of Alpinia galanga Wild. and Their Anti-Ulcer Activities. Chem. Pharm. Bull. 24 (1976) 2377-2382
78. Jansen A.M., and Scheffer J.J.C. Acetoxychavicol Acetate, An Antifungal Compounent of Alpinia galanga. Planta Medica 51 (1985) 507-511
79. Noro T., Sekiya T., Katoh M., Oda Y., Miyase T., Kuroyanagi M., Ueno A., and Fukushima S. Inhibitors of Xanthine Oxidase from Alpinia galanga. Chem. Pharm. Bull. 36 (1988) 244-248
80. Itokawa H., Ichihara Y., Mochizuki M., Enomori T., Morita H., Shirota O., Inamatsu M., and Takeya K. A Cytotoxic Substance from Sangre de Grado. Chem. Pharm. Bull. 39 (1991) 1041-1042
81. Itokawa H., Takeya K., Mihashi S., Mori M., Hamanaka T., Sonobe T., and Iitaka Y. Chem. Pharm. Bull. 31 (1983) 1424
82. Itokawa H., Takeya K., Mori N., Hamanaka T., Sonobe T., and Mihara K. Chem. Pharm. Bull. 32 (1984) 284
83. Itokawa H., Takeya K., Moei M., Sonobe T., Serisawa N., Hamanaka T., and Mihashi S. Chem. Pharm. Bull. 52 (1984) 3216
84. Itokawa H., Takeya K., Mori N., Kidokoro S., and Hamanaka T. Planta Medica 51 (1984) 313
85. Itokawa H., Morita H., Takeya K., Tomioka N., Itai A., and Iitaka Y. Tetrahedron 47 (1991) 7007
86. Itokawa H., Takeya K., Mori N., Sonobe T., Mihashi S., and Hamanaka T. Chem. Pharm. Bull. 34 (1986) 3762
87. Itokawa H., Yamamiya T., Morita H., and Takeya K. J. Chem. Soc Perkin Trans (1992) 1-5
88. Morita H., Yamamiya T., Takeya K., and Itokawa H. Chem. Pharm. Bull. 40 (1992) 1352
89. Takeya K., Yamamiya T., Morita H., and Itokawa H. Phytochemistry 33 (1993) 613
90. Itokawa H., Morita H., Takeya K., Tomioka N., and Itai A. Chem. Lett. (1991) 2217
91. Joladt S.D., Hoffman J.J., Torrance S.J., Wiedhoff R.M., Cole J.R., Arora S.K., Bates R.B., Gargiulo R.L., and Kriek G.R. J. Amer. Chem. Soc. 99 (1977) 8040
92. Bates R.B., Cole J., Hoffman J.J., Kriek G.R., Linz G.S., and Torrance S.J. J. Amer. Chem. Soc. 105 (1983) 1343
93. Itokawa H., Takeya K., Mori N., Takanashi M., Yamamoto H., Sonobe T., and Kidokoro S. Gann 75 (1984) 929
94. Itokawa H., Takeya K., Mori N., Sonobe T., Hamanaka T., Mihashi S., Takanashi M., and Yamamoto H. J. Phamabio-Dun. 8 (1985) s-63
95. V.Sirdeshpande B., and Toogood P.L. Bioorg. Chem. 23 (1995) 460
96. Inoue K., Mukaiyama T., Kobayashi T., and Ogawa M. Investigational New Drugs 4 (1986) 231
97. Itokawa H., Saitou K., Morita H., Takeya K., and Yamada K. Peptide Chemistry (1991) 357
98. Itokawa H., Saitou K., Morita H., Takeya K., and Yamada K. Chem. Pharm. Bull. 40 (1992) 2984
99. Morita H., amamiya T.Y., Takeya K., Itokawa H., Sakuma C., Yamada J., and Suga T. Chem. Pharm. Bull. 41 (1993) 781
100. Jolad S.D., Hoffmann J.J., Torrance S.J., Wiedhopf R.M., Cole J.R., Arora S.K., Bates R.B., Gargiulo R.L., and Kriek G.R. J. Am. Chem. Soc. 99 (1977) 8040
101. Morita H., Kondo K., Hitotsuyanagi Y., Takeya K., Itokawa H., Tomioka N., Itai A., and litaka Y. Tetrahedron 47 (1991) 2757
102. Itokawa H., Morita H., Takeya K., Tomioka N., Itai A., and Iitaka Y. Tetrahedron 47 (1991) 7007
103. Itokawa H., Morita H., Kondo K., Hitotsuyanagi Y., Takeya K., and Iitaka Y. J. Chem. Soc. Perkin Trans. 1 (1992) 1635
104. Hoffmann J.J., Torrance S.J., and Cole J.R. J. Chromatogr. Sci. 17 (1978) 287
105. Bates R.B., Cole J.R., Hoffmann J.J., Kriek G.R., Linz G.S., and Torrance S.J. J. Am. Chem. Soc. 105 (1983) 1343
106. Boger D.L., Patane M.A., and Zhou J. J. Am. Chem. Soc. 117 (1995) 7357
107. Itokawa H., Morita H., and Takeya K. Chem. Pharm. Bull. 40 (1992) 1050
108. Itokawa H., Saitou K., Morita H., and Takeya K. Chem. Pharm. Bull. 39 (1991) 2161
109. Boger D.L., and Zhou J. J. Am. Chem. Soc. 117 (1995) 7364
110. Itokawa H., Saitou K., Morita H., Takeya K., and Yamada K. Chem. Pharm. Bull. 40 (1992) 2984
111. Itokawa H., Morita H., Takeya K., Tomioka N., and Itai A. Chem Lett. (1991) 2217
112. Morita H., Yamamiyak T., Takeya K., Itokawa H., Sakuma C., Yamada J., and Suga T. Chem. Pharm. Bull. 41 (1993) 781
113. Senn H., Loosli H.-R., Sanner M., and Braun W. Biopolymers 29 (1990) 1387
114. Bates R.B., Gin S.L., Hassen M.A., Hruby V.J., Janda K.D., Kriek G.R., Michaud J.-P., and Vine D.B. Heterocycles 22 (1984) 785
115. Boger D.L., and Yohannes D. J. Org. Chem. 53 (1988) 487
116. Boger D.L., and Yohannes D. Synlett (1990) 33
117. Boger D.L., and Myers Jr. J.B. J. Org. Chem. 56 (1991) 5383
118. Boger D.L., Yohannes D., and Myers Jr. J.B. J. Org. Chem. 57 (1992) 1319
119. Boger D.L., Yohannes D., Zhou J., and Patane M.A. J. Am. Chem. Soc. 115 (1993) 3420
120. Boger D.L., Patane M.A., Jin Q., and Kitos P.A. Bioorg. Med. Chem. 2 (1994) 85
121. Itokawa H., Kondo K., Hitotsuyanagi Y., Nakamura A., Morita H., and Takeya K. Chem. Pharm. Bull. 41 (1993) 1266
122. Hitotsuyanagi Y., Lee S., Ito I., kondo K., Takeya K., Yamagishi T., Nagate T., and Itokawa T. J. Chem. Soc, Perkin Trans. 1 (1996) 213
123. Itokawa H., Takeya K., Mori N., Sonobe T., Serizawa N., Hamanaka T., and Mihashi S. Chem. Pharm. Bull. 32 (1984) 3216
124. Itokawa H., Kondo K., Hitotsuyanagi Y., Isomura M., and Takeya K. Chem. Pharm. Bull. 42 (1993) 1402
125. Itokawa H., Kondo K., Hitotsuyanagi Y., and Takeya K. Heterocycles 36 (1993) 1837
126. Boger D.L., and Zhou J. J. Am. Chem. Soc. 117 (1995) 7364
127. Itokawa H., Suzuki J., Hitotsuyanagi Y., Kondo K., and Takeya K. Chem. Lett. (1993) 695
128. Hitotsuyanagi Y., Suzuki J., Takeya K., and Itokawa H. Bioorg. Med. Chem. Lett. 4 (1994) 1633
129. H. Itokawa and Y. Hitotsuyanagi, unpublished results.
130. Hitotsuyanagi Y., Suzuki J., Matsumoto Y., Takeya K., and Itokawa H. J. Chem. Soc, Perkin Trans. 1 (1994) 1887
131. Hitotsuyanagi Y., Matsumoto Y., Sasaki S., Suzuki J., Takeya K., Yamaguchi K., and Itokawa H. J. Chem. Soc., Perkin Trans. 1 (1996) 1749
132. Boger D.L., Zhou J., Winter B., and Kitos P.A. Bioorg. Med. Chem. 5 (1995) 1579
133. Hitotsuyanagi Y., Kondo K., Takeya K., and Itokawa H. Tetrahedron Lett. 55 (1994) 2191
134. Kosemura S., Ogawa T., and Totsuka K. Tetrahedron Lett. 34 (1993) 1291
135. Morita H., Nagashima S., Takeya K., and Itokawa H. Chem. Pharm. Bull. 41 (1993) 992
136. Nagao T., Okabe H., and Yamauchi T. Chem. Pharm. Bull. 36 (1988) 571
137. Marfey P. Carlsberg Res. Commun. 49 (1984) 591
138. Burke Jr. T.R., Knight M., Chandrasekhar B., and Ferretti J.A. Tetrahedron Lett. 30 (1989) 519
139. Flippin L.A., Jalali-Araghi K., and Brown P.A. J. Org. Chem. 54 (1989) 3006
140. Morita H., Nagashima S., Takeya K., Itokawa H., and Iitaka Y. Tetrahedron 51 (1995) 1121
141. Morita H., Nagashima S., Shirota O., Takeya K., and Itokawa H. Cherm. Lett. (1993) 1877
142. Morita H., Nagashima S., Takeya K., and Itokawa H. Heterocycles 38 (1994) 2247
143. Morita H., Nagashima S., Takeya K., and Itokawa H. Cherm. Lett. 11 (1994) 2009
144. Morita H., Nagashima S., Takeya K., and Itokawa H. Chem. Pharm. Bull. 43 (1995) 271
145. Cheng D., Shao Y., Hartman R., Roder E., and Zhao K. Phytochemistry 36 (1994) 945
146. Morita H., Nagashima S., Uchiumi Y., Kuroki O., Takeya K., and Itokawa H. Chem. Pharm. Bull. 44 (1996) 1026
147. Jiang J., Schumacher K.K., Joullie M.M., Davis F.A., and Reddy R.E. Tetrahedron Lett. 35 (1994) 2121
148. Wiliams L., Hauze D.B., and Joullie M.M. Heterocycl Commun. 2 (1996) 55
149. Yoshioka H., Nakatsu K., Sato M., and Tatsuno T. Chem. Lett. (1973) 1319
150. Ciegler A., Kadis S., and Ajl S.J. Microbial Toxins VI Fungal Toxins (1971), Academic Press, Kuala Lumpur, Malaysia 345-352
151. Morita H., Nagashima S., Takeya K., and Itokawa H. Tetrahedron 50 (1994) 11613
152. Morita H., Nagashima S., Takeya K., and Itokawa H. Chem. Pharm. Bull. 43 (1995) 1395
153. Hoshi A., and Kuretani K. Farmacis 9 (1973) 464
154. Morita H., Nagashima S., Takeya K., and Itokawa H. BioMed. Chem. Lett. 5 (1995) 677
155. Morita H., Nagashima S., Takeya K., and Itokawa H. J. Chem. Soc. Perkin Trans. 1 (1995) 2327